| 95388 |
BMC RESEARCH NOTES |
In silico modeling of the pore region of a KCNQ4 missense mutant from a patient with hearing loss |
2012-03-15 |
10.1186/1756-0500-5-145 |
Namba Kazunori, Mutai Hideki, Kaneko Hiroki, Hashimoto Sho, Matsunaga Tatsuo |
| 95387 |
ARCHIVES OF PLASTIC SURGERY : APS |
Absorbable Plate as a Perpendicular Strut for Acute Saddle Nose Deformities |
2012-03-15 |
10.5999/aps.2012.39.2.113 |
Kim, Jong-Gyu, Rhee, Seung-Chul, Cho, Pil-Dong, Kim, Deok-Jung, Lee, Soo-Hyang |
| 95386 |
ARCHIVES OF PLASTIC SURGERY : APS |
Fabrication of Stable Cartilage Framework for Microtia in Incomplete Synchondrosis |
2012-03-15 |
10.5999/aps.2012.39.2.162 |
Cho, Byung-Chae, Lee, Jung-Hun, Choi, Kang-Young, Yang, Jung-Dug, Chung, Ho-Yun |
| 95385 |
ARCHIVES OF PLASTIC SURGERY : APS |
Use of the Fix and Flap Approach to Complex Open Elbow Injury: The Role of the Free Anterolateral Thigh Flap |
2012-03-15 |
10.5999/aps.2012.39.2.130 |
Chui, Christopher Hoe-Kong, Wong, Chin-Ho, Chew, Winston Y., Low, Mun-Hon, Tan, Bien-Keem |
| 95384 |
ARCHIVES OF PLASTIC SURGERY : APS |
Propeller Perforator Flaps in Distal Lower Leg: Evolution and Clinical Applications |
2012-03-15 |
10.5999/aps.2012.39.2.94 |
Georgescu, Alexandru V. |
| 95383 |
ARCHIVES OF PLASTIC SURGERY : APS |
The Effect of Platelet-rich Plasma on Wounds of OLETF Rats Using Expression of Matrix Metalloproteinase-2 and -9 mRNA |
2012-03-15 |
10.5999/aps.2012.39.2.106 |
Shin, Ho-Seong, Oh, Hwa-Young |
| 95382 |
ONCOLOGY REPORTS |
Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells. |
2012-03-15 |
10.3892/or.2012.1726 |
Chen Yongchang |
| 95381 |
ONCOLOGY REPORTS |
The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation. |
2012-03-15 |
10.3892/or.2012.1724 |
Imai Yasuo |
| 95380 |
ONCOLOGY REPORTS |
Livin mediates tumor cell invasion in the DU-145 cell line via NF-관B. |
2012-03-15 |
10.3892/or.2012.1730 |
Song Xishuang |
| 95379 |
ONCOLOGY REPORTS |
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment |
2012-03-15 |
10.3892/or.2012.1732 |
Menendez Javier |
